A look at the safety of metronidazole 1% gel: Cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential

Cutis

Volumn 77, Issue 4 SUPPL., 2006, Pages 12-17

  Beutner, Karl R ^a   Lemke, Shawna ^a,b   Calvarese, Barry ^b  

^a Solano Clinical Research   (United States)

^b Dow Pharmaceutical Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; METRONIDAZOLE;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTACT DERMATITIS; ERYTHEMA; FEMALE; GEL; HUMAN; MALE; PATHOLOGY; PHOTOALLERGY; REVIEW; ROSACEA; SINGLE BLIND PROCEDURE;

DERMATITIS, CONTACT; DERMATITIS, PHOTOALLERGIC; DERMATITIS, PHOTOTOXIC; DERMATOLOGIC AGENTS; ERYTHEMA; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE; ROSACEA; SINGLE-BLIND METHOD;

EID: 33646592564     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3:489-496.
2. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5:543.
3. Buechner SA. Rosacea: an update. Dermatology. 2005;210:100-108.
4. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19: 273-285.
5. Lehmann P. Rosacea. clinical features, pathogenesis and therapy [in German]. Hautarzt. 2005;56:871-885.
6. Gupta AK, Chaudhry M. Topical metronidazole for rosacea. Skin Therapy Lett. 2002;7:1-3, 6.
7. Wolf JE Jr. The role of topical metronidazole in the treatment of rosacea. Cutis. 2004;73(suppl 1):19-28.
8. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351.
9. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987;123:609-614.
10. Espagne E, Guillaume JC, Archimbaud A, et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea. Ann Dermatol Venereol. 1993;120:129-133.
11. Breneman D, Bucko A, Friedman D, et al. Evaluation of topical metronidazole lotion in rosacea. In: Abstracts of the American Academy of Dermatology 56th Annual Meeting; February 27-March 4, 1998; Orlando, Florida. P289.
12. Drake L, Leyden J, Lucky A, et al. Evaluation of topical metronidazole cream in rosacea. In: Abstracts of the American Academy of Dermatology 55th Annual Meeting; March 21-26, 1997; San Francisco, California. P65.
13. Bitar A, Bourgouin J, Dore N, et al. A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea: a placebo-controlled study. Drug Invest. 1990;2:242-248.
14. Bjerke JR, Nyfors A, Austad J, et al. Metronidazole (Elyzol) 1% cream v. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187-194.
15. Breneman DL, Stewart D, Hevia O, et al. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61:44-47.
16. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol 1998;39:502-504.
17. Nielson PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63-65.
18. Odom RB. The subtypes of rosacea: implications for treatment. Cutis. 2004;73(suppl 1):9-14.
19. Data on file. Beutner K. A single center, evaluator-blind evaluation of the cumulative irritation potential of metronidazole gel 1%, vehicle gel and control following repeated topical application to healthy subjects. Study Report 0215-R3.C-05-02. Fort Worth, Tex: Galderma Laboratories LP; 2002.
20. Data on file. Lemke S. A single center, evaluator-blind repeat insult patch test of metronidazole gel 1% and vehicle following repeated topical applications to healthy subjects. Study Report 0215-R3.C-06-02. Fort Worth, Tex: Galderma Laboratories LP; 2004.
21. Data on file. Beutner K. A single center, evaluator-blind evaluation of the phototoxicity potential of metronidazole gel(s) 1%, vehicle(s) following repeated topical application to the skin of healthy subjects. Study Report 0215-R3.C-02-02. Fort Worth, Tex: Galderma Laboratories LP; 2003.
22. Data on file. Beutner K. A single center, evaluator-blind evaluation of the photoallergy potential of metronidazole gel 1%, and vehicle following repeated topical application to healthy subjects. Study Report 0215-R3.C-03-02. Fort Worth, Tex: Galderma Laboratories LP; 2004.
23. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.